This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Aurigene Discovery Technologies Limited, Aurigene Oncology Limited. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 45 
1 out of 19 Years Active: 2022-2025
Title: **Girish Chandrappa Daginakatte: Innovator in Cancer Treatment**
Introduction
Girish Chandrappa Daginakatte, based in Bengaluru, India, is a notable inventor with a strong focus on developing innovative solutions in the field of cancer treatment. With a total of three patents to his name, he has made significant contributions that aim to improve therapeutic methods for various hematological disorders and cancer therapies.
Latest Patents
Among his latest patents, one focuses on the **Combination of small molecule CD-47 inhibitors with other anti-cancer agents**. This invention encompasses a composition that combines a CD47-SIRPα blocking agent with one or more anti-cancer agents. The novel approach involves administering a therapeutically effective amount of the CD47-SIRPα blocking agent, characterized by a specific chemical formula, alongside other anti-cancer treatments to enhance therapeutic efficacy.
Another groundbreaking patent by Daginakatte addresses **Compounds and compositions for treating hematological disorders**. This invention provides effective methods for treating conditions such as acute myeloid leukemia by utilizing substituted heterocyclic compounds and their pharmaceutically acceptable salts that inhibit IRAK4 and FLT-3 kinases. Such advancements hold great promise for improving treatment outcomes in patients suffering from these severe conditions.
Career Highlights
Girish has held crucial roles in prominent organizations such as Aurigene Discovery Technologies and Aurigene Oncology Limited. His work at these companies has enabled him to contribute fundamentally to the development of therapeutics aimed at combating cancer and other serious illnesses.
Collaborations
Daginakatte has collaborated with esteemed colleagues, including Muralidhara Ramachandra and Pottayil Govindan Nair Sasikumar. Their collective expertise in medical research has undoubtedly fostered advancements in the field of pharmaceuticals and increased the impact of their innovative solutions.
Conclusion
With three patents under his belt and innovative approaches to treating various cancers and hematological disorders, Girish Chandrappa Daginakatte stands out as a significant inventor in the medical field. His commitment to enhancing treatment methodologies continues to pave the way for future advancements in cancer therapy, ultimately benefiting countless patients around the world.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile